Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma, Hepatocellular × Leucovorin × Clear all

Phase

Phase 2 13 Phase 3 8 Phase 1 5 Phase 2/3 4 Phase NA 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 24 Pancreatic Neoplasms 17 Colonic Neoplasms 9 Rectal Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Gastrointestinal Neoplasms 5 Esophageal Neoplasms 5 Stomach Neoplasms 4 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Biliary Tract Neoplasms 3 Advanced Solid Tumors 3 Triple Negative Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Melanoma 2 Liver Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Transitional Cell 2 Advanced Solid Tumor 2 Adenocarcinoma Of Esophagus 2 Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Cancer 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Adenocarcinoma Metastatic 1 Pancreatic Adenocarcinoma 1 Neurotoxicity Syndromes 1 Neoplasms, Basal Cell 1 Myelodysplastic Syndromes 1

Interventions

Sorafenib 24 Nivolumab 15 pembrolizumab 13 lenvatinib 10 Bevacizumab 8 Ipilimumab 7 Cyclophosphamide 7 atezolizumab 5 apatinib 5 Specimen Handling 5 tislelizumab 4 durvalumab 4 Radiosurgery 4 Immunotherapy, Adoptive 4 Doxorubicin 4 toripalimab 3 camrelizumab 3 X-Rays 3 Magnetic Resonance Spectroscopy 3 Fluorouracil 3 Everolimus 3 Erlotinib Hydrochloride 3 tremelimumab 2 tepotinib 2 spartalizumab 2 sintilimab 2 sapanisertib 2 fludarabine 2 enzalutamide 2 carotuximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06741020 2025-05-23

HAICI

Zhejiang Cancer Hospital

Phase 1/2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡